Centre for new antibacterial strategies (CANS) is a large interdisciplinary centre at UiT – The Arctic University of Norway for research, education, innovation and dissemination related to antimicrobial resistance (AMR). CANS currently involves sixteen research groups located at three faculties and covers topics within marine bioprospecting – identification and characterization of new antibacterial activities, design and synthesis of new antibiotics and resistance inhibitors, the evolution and molecular epidemiology of AMR, host-microbe-drug interactions, and antibiotic stewardship.
The centre aims to strengthen current activities, but also support new basic research in novel concepts for sustainable antibacterial activities in AMR-prevention and treatment strategies through new permanent and temporary (tenure-track, postdoc and PhD) positions.
Discovery of Antibiotic Resistance in Newly Identified Bacterium
Probiotics reduce AMR carriage, new study shows
In a 2000 strong cohort among newborn babies in Tanzania, the abundance of antibacterial resistant E. coli and Klebsiella pneumoniae decreased by 7 percent when given probiotics.
Illustration of antibiotic resistant E. coli. Foto: Jan Fredrik Frantzen/Adobe Firefly
The study did not find any significant reduction of hospitalization and deaths among the infants, but the reduction in AMR carriage could mean less AMR on a societal scale.
The study was funded by the Western and Northern Norway Regional Health Authorities (Helse Bergen and Helse Nord), The Trond Mohn Foundation, and Joint Programming Initiative on Antimicrobial Resistance (JPIAMR).
To face the rising the problem of antibiotic resistance, UiT and other Norwegian universities are joining forces to educate the next generation of microbial experts.
Associate professor Pauline Cavanagh. Foto: Jan Fredrik Frantzen, UiT
The new researcher school will be called MiMa: Microbiology Matters - novel approaches to tackle future health challenges. With fresh funding from the Norwegian Research Council, the school will educate infection biology scientist with a One Health perspective, including contagion between animals and humans - zoonotic diseases.
The education will strengthen researchers' competence on preventing pandemics and the development of new medicines and vaccines.
- We are all part of the same ecosystem. The COVID-19 pandemic was an example of how fast contagion can spread from animals to humans, and how this contagion can spread globally. By having knowledge about surveillance of other sources of contagion like domestic animals and wild game, we can prevent potential outbreaks or spread to humans, says associate professor Pauline Cavanagh from UiT.
Cavanagh will head the school together with professor Morten Kjos from the Norwegian University of Life Sciences (NMBU).
MiMa: Microbiology Matters is a cooperative effort between UiT, The University of Oslo, The University of Bergen, NTNU in Trondheim, the Norwegian University of Life Sciences, OsloMet, and the University of Inland Norway. MiMa will also cooperate with industry and other Norwegian research institutions.
Discovery of Antibiotic Resistance in Newly Identified Bacterium
Staphylococcus borealis has been found to be resistant to several different types of antibiotics, posing a potentially significant problem for the elderly.
Scientists have began to unravel the mysteries of the bacteria discovered in 2020. And there is probably more to come. Foto: Jan Fredrik Frantzen, UiT
In 2020, a research group at UiT The Arctic University of Norway in Tromsø discovered a previously unknown bacterium. You may have heard of Staphylococcus aureus (golden staph), but this one belongs to the white variety.
The newcomer, discovered in Tromsø in Northern Norway, was proudly named Staphylococcus borealis (S. borealis) after the Northern Lights.
But how dangerous is it really, and is it a threat to us at all?
33 Percent Antibiotic Resistance
To investigate, researchers collected bacterial samples stored in freezers at several Norwegian hospitals.
The samples went as far back as 2014, and the researchers conducted new tests to see if they could identify the new bacterium in the old samples. Meanwhile, new samples arriving at the UiT lab from 2020 to 2024 were tested continuously. In total, the researchers collected and analysed 129 samples from seven Norwegian hospitals.
It turns out that S. borealis is resistant to more than three different classes of antibiotics in one-third of the cases where it was tested.
"We see the most resistance against the antibiotic classes fusidic acid, cephalosporins, penicillins, macrolides, and fluoroquinolones," explains Jorunn Pauline Cavanagh, who led the work on bacterial analyses.
Moreover, the bacterium also appears to be highly adept at acquiring protective mechanisms from other bacterial species. This means it could potentially develop antibiotic resistance quickly, when attacked with the medicines currently available.
A Problem for the Elderly
S. borealis is a bacterium that lives on our skin, and researchers have found that it can become problematic when your immune system is weakened. This makes it particularly concerning for the elderly and for those who have had knee or hip replacements.
"This bacterium is an opportunist that can cause illness when your immune system is compromised. For example, we see that it can form what’s called biofilm around knee prostheses and cause infections that can be difficult to treat," explains Jorunn Pauline Cavanagh.
Researchers are now working to determine which diseases this bacterium can cause. Preliminary findings suggest it may lead to urinary tract infections, as well as inflammation in areas where implants are present.
"We do know that it causes mastitis in dromedary camels. This is because we’ve published the bacterium’s genetic profile in international databases, which other researchers use to compare their own bacterial findings. So, more possibilities may emerge," says Cavanagh.
Contact Information
Jorunn Pauline Cavanagh Associate professor at UiT The Arctic University of Norway Phone: +47 40 49 84 90